| Announce Date | 01/30/2026 |
| EPS Normalized Actual | $1.71 (Beat by $0.01) |
| EPS GAAP Actual | $1.71 (Beat by $0.01) |
| Revenue Actual | $83.426B |
| Revenue Surprise | Beat by $83426M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 12.12 | 12.38 | 10.9718 | 13.84349 | 2 |
| Dec 2029 | 11.84383 | 12.67 | 10.22966 | 13.28584 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.72 | 1.72 | 83.426B | -1.1% | 83426M |
| FQ3 2025 (Sep 2025) | 1.92 | 1.92 | 90.016B | -0.83% | 90016M |
| FQ2 2025 (Jun 2025) | 2.14 | 2.14 | 93.06B | 3.3% | 93060M |
| FQ1 2025 (Mar 2025) | 0 | 0 | 0B | -INF% | 0M |
| FQ4 2024 (Dec 2024) | 1.71 | 1.71 | 84.344B | 3.15% | 84344M |
| FQ3 2024 (Sep 2024) | 2.1 | 2.1 | 90.76B | 2.41% | 90760M |
| FQ2 2024 (Jun 2024) | 2.14 | 2.14 | 89.986B | 10.21% | 89986M |
| FQ1 2024 (Mar 2024) | 2.06 | 2.06 | 80.411B | -4.02% | 80411M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2030 (Jun 2030) | 2.46 | -- | 2.16207 | 2.64545 | 8 |
| FQ1 2030 (Mar 2030) | 2.48 | -- | 2.17965 | 2.66696 | 5 |
| FQ4 2029 (Dec 2029) | 2.09 | -- | 1.70823 | 2.66415 | 4 |
| FQ3 2029 (Sep 2029) | 2.5 | -- | 2.19719 | 2.91769 | 8 |
| FQ2 2029 (Jun 2029) | 2.51 | -- | 2.20598 | 2.92936 | 8 |
| FQ1 2029 (Mar 2029) | 2.46 | -- | 2.16203 | 2.87101 | 8 |
| FQ4 2028 (Oct 2028) | 2.86 | -- | 2.16072 | 3.32599 | 10 |
| FQ3 2028 (Jul 2028) | 2.84 | -- | 2.14561 | 3.30274 | 7 |
| FQ2 2028 (Jun 2028) | 2.84 | -- | 2.48837 | 3.28814 | 5 |
| FQ1 2028 (Mar 2028) | 2.52 | -- | 2.30794 | 3.08926 | 6 |
| FQ4 2027 (Dec 2027) | 2.39 | -- | 2.09409 | 2.76713 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2030 (Jun 2030) | 88.72B | -- | 80.46B | 93.87B | 3 |
| FQ1 2030 (Mar 2030) | 88.8B | -- | 80.52B | 93.95B | 3 |
| FQ4 2029 (Dec 2029) | 87.66B | -- | 75.34B | 106.18B | 1 |
| FQ3 2029 (Sep 2029) | 86.76B | -- | 78.68B | 97.91B | 3 |
| FQ2 2029 (Jun 2029) | 86.71B | -- | 78.63B | 97.86B | 3 |
| FQ1 2029 (Mar 2029) | 86.81B | -- | 78.72B | 97.97B | 3 |
| FQ4 2028 (Oct 2028) | 78.92B | -- | 64.08B | 88.81B | 2 |
| FQ3 2028 (Jul 2028) | 78.9B | -- | 64.06B | 88.78B | 2 |
| FQ2 2028 (Jun 2028) | 78.9B | -- | 71.38B | 88.47B | 2 |
| FQ1 2028 (Mar 2028) | 77.47B | -- | 72.46B | 90.93B | 4 |
| FQ4 2027 (Dec 2027) | 77.63B | -- | 70.24B | 87.06B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.72 | 1.72 | 100% | |
| FQ3 2025 (Sep 2025) | 1.92 | 1.92 | 100% | |
| FQ2 2025 (Jun 2025) | 2.14 | 2.14 | 100% | |
| FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Dec 2024) | 1.71 | 1.71 | 100% | |
| FQ3 2024 (Sep 2024) | 2.1 | 2.1 | 100% | |
| FQ2 2024 (Jun 2024) | 2.14 | 2.14 | 100% | |
| FQ1 2024 (Mar 2024) | 2.06 | 2.06 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $83.43B | $83426M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $90.02B | $90016M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $93.06B | $93060M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $84.34B | $84344M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $90.76B | $90760M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $89.99B | $89986M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $80.41B | $80411M | 100% |